IMMUNOME INC (IMNM) Institutional Ownership and Insiders Activity

IMMUNOME INC (IMNM) is widely held by institutional investors, with 200 firms reporting positions valued at approximately $2.52B based on SEC Form 13F filings for the quarter ended June 30, 2026.

T. Rowe Price Investment Management, Inc. is the largest disclosed holder, reporting approximately $416.95M in IMNM holdings in its latest filing.

Recent insider activity includes 18 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.